Genome & Company (KOSDAQ: 314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,945.00
+170.00 (6.13%)
Jan 3, 2025, 9:00 AM KST

Genome & Company Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
57,51856,35672,21636,049103,94821,938
Short-Term Investments
9,27818,86328,20535,2495,6403,686
Trading Asset Securities
11,41011,0536,2785,865-5,000
Cash & Short-Term Investments
78,20786,272106,69977,164109,58830,624
Cash Growth
-21.75%-19.14%38.28%-29.59%257.85%-
Accounts Receivable
1,2951,4021,957759.22--
Other Receivables
1,3721,544864.23992.141,377356.06
Receivables
2,6672,9462,8211,7511,377356.06
Inventory
5,6193,5682,2381,327--
Prepaid Expenses
771.841,1501,1591,102243.77125.24
Other Current Assets
1,4713,1143,994433.1571.28371.48
Total Current Assets
88,73697,050116,90981,777111,28031,477
Property, Plant & Equipment
35,36834,62421,52616,4754,2712,926
Long-Term Investments
------0
Goodwill
14,13314,13316,45816,4581,063-
Other Intangible Assets
8,95311,10213,92118,3883,811329.5
Other Long-Term Assets
4,5845,1524,1824,119457.17452.65
Total Assets
151,774162,060172,997137,216120,88335,185
Accounts Payable
541.78340.19205.18321.4--
Accrued Expenses
2,0372,7233,4281,713316.7656.33
Short-Term Debt
15,73811,997----
Current Portion of Leases
1,1311,0552,0241,583580.26417.76
Other Current Liabilities
9,96212,1165,4846,2082,11164,986
Total Current Liabilities
29,40928,23111,1419,8263,00866,060
Long-Term Debt
10,3159,637---5,850
Long-Term Leases
3,3733,7644,2675,2431,1791,132
Long-Term Deferred Tax Liabilities
3,9064,4145,5826,826782.66-
Other Long-Term Liabilities
2,6732,4971,4621,921830.66114.36
Total Liabilities
49,67648,54322,45223,8165,80073,156
Common Stock
15,4857,3637,0467,0336,6524,113
Additional Paid-In Capital
296,424304,765304,724257,345246,88073,810
Retained Earnings
-297,987-284,659-237,193-185,355-151,238-120,505
Comprehensive Income & Other
36,66234,24021,78413,7109,1392,906
Total Common Equity
50,58461,70896,36092,733111,434-39,676
Minority Interest
50,60651,08953,24820,6673,371-
Shareholders' Equity
102,097113,517150,544113,400115,083-37,971
Total Liabilities & Equity
151,774162,060172,997137,216120,88335,185
Total Debt
30,55726,4536,2916,8261,7597,399
Net Cash (Debt)
47,65059,819100,40870,338107,82923,225
Net Cash Growth
-40.30%-40.42%42.75%-34.77%364.28%-
Net Cash Per Share
2295.502118.263566.882616.465599.591448.66
Filing Date Shares Outstanding
30.9729.4528.1828.1326.6116.03
Total Common Shares Outstanding
30.9729.4528.1828.1326.6116.03
Working Capital
59,32768,819105,76971,952108,272-34,584
Book Value Per Share
1633.282095.343419.083296.304187.69-2474.79
Tangible Book Value
27,49836,47365,98157,888106,559-40,005
Tangible Book Value Per Share
887.871238.472341.162057.684004.50-2495.34
Land
2,7102,71010.59---
Buildings
9,2519,220----
Machinery
17,21415,83814,6629,1673,0261,498
Construction In Progress
9,4298,4924,2452,26219.45350
Source: S&P Capital IQ. Standard template. Financial Sources.